Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: IGGENIX, INC.
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2024-09-04 to 2025-09-26
Current total value of award: $100000
Description: FEL D 1-SPECIFIC HUMAN IGE CLASS SWITCHED TO IGE MONOCLONAL ANTIBODIES